Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 238

1.

A randomized clinical trial of photodynamic therapy with methyl aminolaevulinate vs. diclofenac 3% plus hyaluronic acid gel for the treatment of multiple actinic keratoses of the face and scalp.

Zane C, Facchinetti E, Rossi MT, Specchia C, Calzavara-Pinton PG.

Br J Dermatol. 2014 May;170(5):1143-50. doi: 10.1111/bjd.12844.

PMID:
24506666
2.

Daylight photodynamic therapy for actinic keratoses: a randomized double-blinded nonsponsored prospective study comparing 5-aminolaevulinic acid nanoemulsion (BF-200) with methyl-5-aminolaevulinate.

Neittaanmäki-Perttu N, Karppinen TT, Grönroos M, Tani TT, Snellman E.

Br J Dermatol. 2014 Nov;171(5):1172-80. doi: 10.1111/bjd.13326. Epub 2014 Oct 15.

PMID:
25109244
3.
4.

A randomized split-face clinical trial analyzing daylight photodynamic therapy with methyl aminolaevulinate vs ingenol mebutate gel for the treatment of multiple actinic keratoses of the face and the scalp.

Moggio E, Arisi M, Zane C, Calzavara-Pinton I, Calzavara-Pinton P.

Photodiagnosis Photodyn Ther. 2016 Dec;16:161-165. doi: 10.1016/j.pdpdt.2016.08.005. Epub 2016 Aug 13.

PMID:
27530375
5.

A randomized, multicentre study of directed daylight exposure times of 1½ vs. 2½ h in daylight-mediated photodynamic therapy with methyl aminolaevulinate in patients with multiple thin actinic keratoses of the face and scalp.

Wiegell SR, Fabricius S, Stender IM, Berne B, Kroon S, Andersen BL, Mørk C, Sandberg C, Jemec GB, Mogensen M, Brocks KM, Philipsen PA, Heydenreich J, Haedersdal M, Wulf HC.

Br J Dermatol. 2011 May;164(5):1083-90. doi: 10.1111/j.1365-2133.2011.10209.x. Epub 2011 Apr 5.

PMID:
21219287
6.

Daylight-mediated photodynamic therapy of moderate to thick actinic keratoses of the face and scalp: a randomized multicentre study.

Wiegell SR, Fabricius S, Gniadecka M, Stender IM, Berne B, Kroon S, Andersen BL, Mørk C, Sandberg C, Ibler KS, Jemec GB, Brocks KM, Philipsen PA, Heydenreich J, Hædersdal M, Wulf HC.

Br J Dermatol. 2012 Jun;166(6):1327-32. doi: 10.1111/j.1365-2133.2012.10833.x.

PMID:
22250644
7.

Conventional vs. daylight methyl aminolevulinate photodynamic therapy for actinic keratosis of the face and scalp: an intra-patient, prospective, comparison study in Italy.

Fargnoli MC, Piccioni A, Neri L, Tambone S, Pellegrini C, Peris K.

J Eur Acad Dermatol Venereol. 2015 Oct;29(10):1926-32. doi: 10.1111/jdv.13076. Epub 2015 Mar 23.

PMID:
25809617
8.

Daylight photodynamic therapy with methyl aminolevulinate cream as a convenient, similarly effective, nearly painless alternative to conventional photodynamic therapy in actinic keratosis treatment: a randomized controlled trial.

Rubel DM, Spelman L, Murrell DF, See JA, Hewitt D, Foley P, Bosc C, Kerob D, Kerrouche N, Wulf HC, Shumack S.

Br J Dermatol. 2014 Nov;171(5):1164-71. doi: 10.1111/bjd.13138. Epub 2014 Oct 20.

PMID:
24861492
9.

Daylight photodynamic therapy with methyl aminolevulinate cream is effective and nearly painless in treating actinic keratoses: a randomised, investigator-blinded, controlled, phase III study throughout Europe.

Lacour JP, Ulrich C, Gilaberte Y, Von Felbert V, Basset-Seguin N, Dreno B, Girard C, Redondo P, Serra-Guillen C, Synnerstad I, Tarstedt M, Tsianakas A, Venema AW, Kelleners-Smeets N, Adamski H, Perez-Garcia B, Gerritsen MJ, Leclerc S, Kerrouche N, Szeimies RM.

J Eur Acad Dermatol Venereol. 2015 Dec;29(12):2342-8. doi: 10.1111/jdv.13228. Epub 2015 Oct 5.

PMID:
26435363
10.
11.
12.

Intraindividual, right-left comparison of topical methyl aminolaevulinate-photodynamic therapy and cryotherapy in subjects with actinic keratoses: a multicentre, randomized controlled study.

Morton C, Campbell S, Gupta G, Keohane S, Lear J, Zaki I, Walton S, Kerrouche N, Thomas G, Soto P; AKtion Investigators.

Br J Dermatol. 2006 Nov;155(5):1029-36.

PMID:
17034536
13.

Artificial White Light vs Daylight Photodynamic Therapy for Actinic Keratoses: A Randomized Clinical Trial.

O'Gorman SM, Clowry J, Manley M, McCavana J, Gray L, Kavanagh A, Lally A, Collins P.

JAMA Dermatol. 2016 Jun 1;152(6):638-44. doi: 10.1001/jamadermatol.2015.5436.

PMID:
26843523
14.

Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo.

Dirschka T, Radny P, Dominicus R, Mensing H, Brüning H, Jenne L, Karl L, Sebastian M, Oster-Schmidt C, Klövekorn W, Reinhold U, Tanner M, Gröne D, Deichmann M, Simon M, Hübinger F, Hofbauer G, Krähn-Senftleben G, Borrosch F, Reich K, Berking C, Wolf P, Lehmann P, Moers-Carpi M, Hönigsmann H, Wernicke-Panten K, Helwig C, Foguet M, Schmitz B, Lübbert H, Szeimies RM; AK-CT002 Study Group.

Br J Dermatol. 2012 Jan;166(1):137-46. doi: 10.1111/j.1365-2133.2011.10613.x. Epub 2011 Dec 21.

PMID:
21910711
15.

Fractional erbium: YAG laser-assisted photodynamic therapy for facial actinic keratoses: a randomized, comparative, prospective study.

Ko DY, Jeon SY, Kim KH, Song KH.

J Eur Acad Dermatol Venereol. 2014 Nov;28(11):1529-39. doi: 10.1111/jdv.12334. Epub 2013 Dec 17.

PMID:
24341367
16.

The clinical efficacy of topical methyl-aminolevulinate photodynamic therapy in moderate to severe actinic keratoses of the face and scalp.

Kleinpenning MM, van de Kerkhof PC, Gerritsen RM.

J Dermatolog Treat. 2010 Jul;21(4):252-7. doi: 10.3109/09546630903271555.

PMID:
19832288
17.

Topical corticosteroid reduces inflammation without compromising the efficacy of photodynamic therapy for actinic keratoses: a randomized clinical trial.

Wiegell SR, Petersen B, Wulf HC.

Br J Dermatol. 2014 Dec;171(6):1487-92. doi: 10.1111/bjd.13284. Epub 2014 Oct 30.

PMID:
25060803
18.

Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up.

Tschen EH, Wong DS, Pariser DM, Dunlap FE, Houlihan A, Ferdon MB; Phase IV ALA-PDT Actinic Keratosis Study Group.

Br J Dermatol. 2006 Dec;155(6):1262-9.

PMID:
17107399
19.

Supplemental Content

Support Center